Lab-grown lung cancer cells show potential to revolutionise treatment
The model could lead to more targeted treatments for the disease
Read MoreThe model could lead to more targeted treatments for the disease
Read Moreby Emily Kimber | Oct 22, 2024 | News | 0
The company’s workforce will volunteer and fundraise for Team Jak throughout the year
Read Moreby PharmaTimes | Aug 28, 2024 | News | 0
The partnership will improve care for patients with pancreatic cancer
Read Moreby PharmaTimes | Aug 27, 2024 | News | 0
Over 135,000 people have signed a petition to prioritise a national screening programme
Read Moreby PharmaTimes | Aug 23, 2024 | News | 0
Most cases go undetected until an advanced stage, as the disease rarely causes early symptoms
Read Moreby PharmaTimes | Aug 19, 2024 | News | 0
In the UK study, researchers analysed 2,023 bowel cancers from the 100,000 Genomes Project
Read Moreby Jen Brogan | Aug 16, 2024 | News | 0
This form of cancer was responsible for 1.9 million diagnosed cases worldwide in 2020
Read Moreby Jen Brogan | Aug 12, 2024 | News | 0
Bowel cancer was the most common cancer to be identified in both men and women
Read Moreby Jen Brogan | Aug 5, 2024 | News | 0
Bowel cancer, the third most common cancer type worldwide, is the second most common cause of cancer death
Read Moreby Jen Brogan | Aug 2, 2024 | News | 0
The third leading cause of cancer mortality accounts for over 700,000 deaths every year
Read Moreby Jen Brogan | Aug 2, 2024 | News | 0
Cancer is estimated to affect more than three million people living in the UK, according to Macmillan Cancer Support
Read Moreby Jen Brogan | Aug 1, 2024 | News | 0
Combined, ovarian and breast cancer affect over 60,000 women in the UK every year
Read MorePharmaTimes Media Ltd.
Mansard House
Church Road
Little Bookham
Leatherhead
Surrey KT23 3JG
E: editorial@pharmatimes.com
E: subscriptions@pharmatimes.com
T: +44 (0)20 7240 6999
F: +44 (0)20 7240 4479